Polymorphous low-grade adenocarcinoma of the major salivary glands: report of three cases in an unusual location

2004 ◽  
Vol 44 (2) ◽  
pp. 164-171 ◽  
Author(s):  
T Nagao ◽  
T A Gaffey ◽  
P A Kay ◽  
H Minato ◽  
H Serizawa ◽  
...  
1989 ◽  
Vol 98 (2) ◽  
pp. 162-163 ◽  
Author(s):  
John G. Batsakis ◽  
Mario A. Luna

Adenocarcinomas of salivary glands are encountered less frequently than adenoid cystic or mucoepidermoid carcinomas. They fall into two well-defined clinicopathologic groups: 1) those arising from intercalated ducts and 2) those from the excretory and interlobular ducts. The former, designated terminal duct adenocarcinomas, are low-grade malignancies found preponderantly in the oral cavity, especially the palate. The latter, designated salivary duct carcinomas, are high-grade neoplasms and arise almost exclusively in major salivary glands, especially the parotid gland.


2012 ◽  
Vol 2 (4) ◽  
pp. 331-334
Author(s):  
S Shrestha ◽  
CB Pun ◽  
R Basyal ◽  
T Pathak ◽  
S Bastola ◽  
...  

Polymorphous low-grade adenocarcinoma is a rare salivary gland malignant tumor of low aggressiveness, commonly occurring in minor salivary glands. Its origin in major salivary glands is considered exceedingly rare. We report a case of polymorphous low grade adenocarcinoma arising from left parotid in a 21-yearold female patient.Journal of Pathology of Nepal (2012) Vol. 2, 331-334DOI: http://dx.doi.org/10.3126/jpn.v2i4.6890


2011 ◽  
Vol 2 (1) ◽  
pp. 57-60 ◽  
Author(s):  
Siddharth Gupta ◽  
C Anand Kumar ◽  
Namita Raghav

ABSTRACT Polymorphous low-grade adenocarcinoma (PLGA) is a malignancy arising predominantly from minor salivary glands. PLGAs account for 10% of all tumors and 25% of all malignancies of the minor salivary glands. It has been frequently described as occurring in hard or soft palate minor salivary glands; some cases being described in the tongue and in major salivary glands. We report a case of PLGA of the palate extending into the maxillary sinus and nasal cavity diagnosed on the basis of histopathology and treated by subtotal maxillectomy. The review of literature concerning clinical, histological and immunohistochemical features, as well as the proper management concerning this tumor is included.


2021 ◽  
Author(s):  
Jingjing Sun ◽  
Sirui Liu ◽  
Kun Fu ◽  
Ning Gao ◽  
Rui Li ◽  
...  

Abstract Background Secretory carcinoma of salivary glands (SCSGs) are generally low-grade salivary gland carcinomas, and are characterized by morphological resemblance to mammary analogue secretory carcinoma and ETV6–NTRK3 gene fusion. Several reports on histopathological features of SCSG have recently been published; however, little is known about the clinical characteristics of this new tumor, including its outcomes. The research is to investigate the clinicopathological characteristics of secretory carcinoma of major salivary glands and to analyze outcomes of these carcinomas as a reference for standardizing their diagnosis and treatment. Methods The cohort of this retrospective study comprised 23 patients treated for histopathologically-confirmed SCSG between January 2010 and December 2020. Their clinical characteristics and outcomes were retrieved from patient files. Results The 23 patients comprised 13 male and 10 female patients (male:female ratio 1.3:1). They were aged 10–69 years (median 45 years) and the average duration of disease was 2.44 years (0.25–20 years). Twenty-one patients (91.3%) had SCSGs in the parotid gland and two (8.7%) in the submandibular gland. All 23 patients had single nodules with diameters of 0.8–4.8 cm (average 2.6 cm). Five patients had lymph node metastases and two had distant metastases. All tumors were pathologically diagnosed as SCSGs. Immunohistochemical staining was strongly positive for S-100, mammaglobin, CK7, and Gata3, and negative for Dog1, P63 and calponin. Ki-67 positivity ranged from 1–50%. Fluorescence in situ hybridization data were available for 15 patients, in all of whom ETV6 gene rearrangement was confirmed. All patients had undergone oncological resections. Four had radioactive particles implanted postoperatively, one received chemotherapy, and seven underwent chemoradiotherapy. Six patients had regional recurrences, two distant metastases, and one had died at the time of last follow-up. Conclusions SCSGs are typically indolent with a low rate of locoregional recurrence and excellent survival. Their prognosis is correlated with clinical stage, pathological grade, and surgical procedures performed.


1971 ◽  
Vol 48 (2) ◽  
pp. 199-200
Author(s):  
S E Tharvaldsson ◽  
O H Beahrs ◽  
L B Woolner ◽  
J B Simons

1994 ◽  
Vol 30 (5) ◽  
pp. 329-334 ◽  
Author(s):  
M. John Hicks ◽  
Adel K. El-Naggar ◽  
Robert M. Byers ◽  
Catherine M. Flaitz ◽  
Mario A. Luna ◽  
...  

1986 ◽  
Vol 408 (5) ◽  
pp. 449-459 ◽  
Author(s):  
Yohko Noda ◽  
Yoshiaki Takai ◽  
Yoshimasa Iwai ◽  
Michael A. Meenaghan ◽  
Masahiko Mori

Sign in / Sign up

Export Citation Format

Share Document